Dose-Dependent Effect of Piragliatin, a Glucokinase Activator, on the QT Interval Following Short-Term Multiple Doses in Patients With Type 2 Diabetes Mellitus

2016 ◽  
Vol 6 (3) ◽  
pp. 258-265 ◽  
Author(s):  
Jianguo Zhi ◽  
Suoping Zhai ◽  
Mark Boldrin
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Qt Interval ◽  
Short Term ◽  
Dependent Effect ◽  
Glucokinase Activator ◽  
Dose Dependent ◽  
Dose Dependent Effect

Dose-ranging study with the glucokinase activator AZD1656 in patients with type 2 diabetes mellitus on metformin

2013 ◽  
Vol 15 (8) ◽  
pp. 750-759 ◽  
Author(s):  
J. P. H. Wilding ◽  
M. Leonsson-Zachrisson ◽  
C. Wessman ◽  
E. Johnsson
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glucokinase Activator ◽  
Dose Ranging

1067-P: Short-Term Risk of Type 2 Diabetes Mellitus in Adults Treated with Corticosteroids: An Observational Study

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 1067-P
Author(s):  
ELLEN BERNI ◽  
SARA JENKINS-JONES ◽  
CAROL ASTBURY ◽  
MARY N. BROWN ◽  
PHILLIP R. HUNT ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Observational Study ◽  
Short Term
Sign in / Sign up

Export Citation Format

Share Document